Dr. Sanjeev Phatak | MBBS | Omnicuris

Home

Courses

MedShots

Survey

Verifying...

Loading, please wait...

About Us Contact Us FAQs Privacy Policy Terms of Use ISO

Download Our Mobile App

Copyright © 2026 Omnicuris Healthcare Pvt Ltd. All rights reserved.

"Wherever the art of Medicine is loved, there is also a love of Humanity."

Hippocrates

Made with❤️byOmnicuris

© 2026 Omnicuris Healthcare Pvt Ltd.

Medshots Help Profile

Dr. Sanjeev Phatak | MBBS | Omnicuris

Dr. Sanjeev Phatak

Medical Expert

Qualification

MBBS

Location

India

Qualification

MBBS

Location

India

Educational Content

9 Sessions

D2 P2 Discussion 1

D2 P2 Discussion 1

Early & Appropriate Treatment of Diabetic Dyslipidemia in Indian Phenotype

Early & Appropriate Treatment of Diabetic Dyslipidemia in Indian Phenotype

BLUE INDEX-A motivational health score, our 3 year experience

BLUE INDEX-A motivational health score, our 3 year experience

SGLT2i as First Line Therapy in T2DM? Yes / No

SGLT2i as First Line Therapy in T2DM? Yes / No

Discussion 7

Discussion 7

Managing Diabetic Dyslipidaemia in Asian Indians: Meeting Targets

Managing Diabetic Dyslipidaemia in Asian Indians: Meeting Targets

Management of Diabetic Dyslipidemia in Asian Indians: Meeting Targets, Saving Lives

Management of Diabetic Dyslipidemia in Asian Indians: Meeting Targets, Saving Lives

Measurement of Cardiovascular Risk in Indian Type 2 Diabetes Patients

Measurement of Cardiovascular Risk in Indian Type 2 Diabetes Patients

Premix as an option: Trade-off between convenience and efficacy

Premix as an option: Trade-off between convenience and efficacy